Patent: 7,335,761
✉ Email this page to a colleague
Summary for Patent: 7,335,761
Title: | Avian gene expression controlling regions |
Abstract: | The present invention includes avian ovomucoid gene expression controlling regions which may be operably linked to one or more useful amino acid coding sequences. |
Inventor(s): | Harvey; Alex J. (Athens, GA), Leavitt; Markley C. (Watkinsville, GA), Wang; Youliang (Monroe, GA) |
Assignee: | AviGenics, Inc. (Athens, GA) |
Application Number: | 11/047,184 |
Patent Claims: | see list of patent claims |
Details for Patent 7,335,761
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM | follitropin beta | For Injection | 020582 | 09/29/1997 | ⤷ Try a Trial | 2021-11-30 |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 04/20/2000 | ⤷ Try a Trial | 2021-11-30 |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 04/25/2007 | ⤷ Try a Trial | 2021-11-30 |
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ CARTRIDGE | follitropin beta | Injection | 021211 | 03/23/2004 | ⤷ Try a Trial | 2021-11-30 |
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ CARTRIDGE | follitropin beta | Injection | 021211 | 02/11/2005 | ⤷ Try a Trial | 2021-11-30 |
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | FOLLISTIM AQ | follitropin beta | Injection | 021273 | 08/26/2005 | ⤷ Try a Trial | 2021-11-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |